{"transactions":[{"id":4541,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-09-04T20:27:42.000Z","date":"2026-09-03","kind":"sale","planned":true,"acquired":false,"shares":709,"price":3.0372,"value":2153.3748,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on September 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $3.0050 to $3.0372. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61660,"source":{"system":"sec-edgar","filing":"0001985604-26-000003","document":"wk-form4_1788553659.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1985604/000198560426000003/wk-form4_1788553659.xml","form_type":"4"}},{"id":701306,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-07-29T20:51:02.000Z","date":"2026-07-28","kind":"sale","planned":true,"acquired":false,"shares":4928,"price":2.67,"value":13157.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2026. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":62369,"source":{"system":"sec-edgar","filing":"0001650664-26-000076","document":"wk-form4_1785358259.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000076/wk-form4_1785358259.xml","form_type":"4"}},{"id":747456,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-06-05T20:32:35.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":731,"price":2.7011,"value":1974.5041,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on June 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.7010 to $2.7050.  The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":67297,"source":{"system":"sec-edgar","filing":"0001650664-26-000055","document":"wk-form4_1780691552.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000055/wk-form4_1780691552.xml","form_type":"4"}},{"id":841090,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2026-03-16T20:34:51.000Z","date":"2026-03-12","kind":"grant","planned":true,"acquired":true,"shares":292856,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 12, 2026 and is scheduled to vest over four years in equal monthly installments beginning on April 12, 2026 through March 12, 2030."}],"balance_after":292856,"derivative":{"exercise_price":2.54,"expiration_date":"2036-03-11","underlying":"Common Stock","underlying_shares":292856},"source":{"system":"sec-edgar","filing":"0001650664-26-000021","document":"wk-form4_1773693286.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000021/wk-form4_1773693286.xml","form_type":"4"}},{"id":860631,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2026-03-04T21:48:40.000Z","date":"2026-03-03","kind":"sale","planned":true,"acquired":false,"shares":749,"price":2.0196,"value":1512.6804,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on March 2, 2026. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.0041 to $2.0204. The price reported above reflects the weighted average purchase price. The Reporting Person hereby\nundertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected"}],"balance_after":68028,"source":{"system":"sec-edgar","filing":"0001650664-26-000006","document":"wk-form4_1772660918.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066426000006/wk-form4_1772660918.xml","form_type":"4"}},{"id":979974,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-12-04T21:39:10.000Z","date":"2025-12-03","kind":"sale","planned":true,"acquired":false,"shares":713,"price":2.1531,"value":1535.1603,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":68777,"source":{"system":"sec-edgar","filing":"0001650664-25-000163","document":"wk-form4_1764884348.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000163/wk-form4_1764884348.xml","form_type":"4"}},{"id":1047518,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-09-04T20:21:27.000Z","date":"2025-09-03","kind":"sale","planned":true,"acquired":false,"shares":710,"price":2.5961,"value":1843.231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax\nwithholding obligations as a result of vesting in restricted stock units on September 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned following the reported transaction includes 5,802 shares acquired under the Issuer's Employee Stock Purchase Plan."}],"balance_after":69490,"source":{"system":"sec-edgar","filing":"0001650664-25-000143","document":"wk-form4_1757017284.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000143/wk-form4_1757017284.xml","form_type":"4"}},{"id":1075981,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-08-04T20:49:50.000Z","date":"2025-07-31","kind":"sale","planned":true,"acquired":false,"shares":5121,"price":2.4911,"value":12756.9231,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":64398,"source":{"system":"sec-edgar","filing":"0001650664-25-000113","document":"wk-form4_1754340586.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000113/wk-form4_1754340586.xml","form_type":"4"}},{"id":1122361,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-06-04T22:37:51.000Z","date":"2025-06-03","kind":"sale","planned":true,"acquired":false,"shares":726,"price":1.7243,"value":1251.8418,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on June 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $1.7239 to $1.7522. The price reported above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request, to the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":69519,"source":{"system":"sec-edgar","filing":"0001650664-25-000091","document":"wk-form4_1749076666.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000091/wk-form4_1749076666.xml","form_type":"4"}},{"id":1189485,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:33:48.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":70000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on March 8, 2025 and is scheduled to vest in full on September 8, 2026."}],"balance_after":70000,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":70000},"source":{"system":"sec-edgar","filing":"0001650664-25-000034","document":"wk-form4_1743107610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000034/wk-form4_1743107610.xml","form_type":"4"}},{"id":1189484,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2025-03-27T20:33:48.000Z","date":"2025-03-08","kind":"grant","planned":false,"acquired":true,"shares":275100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted on March 8, 2025 and is scheduled to vest over four years in equal monthly installments beginning on April 8, 2025 through March 8, 2029."}],"balance_after":275100,"derivative":{"exercise_price":1.72,"expiration_date":"2035-03-07","underlying":"Common Stock","underlying_shares":275100},"source":{"system":"sec-edgar","filing":"0001650664-25-000034","document":"wk-form4_1743107610.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000034/wk-form4_1743107610.xml","form_type":"4"}},{"id":1221565,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2025-03-05T21:41:55.000Z","date":"2025-03-04","kind":"sale","planned":true,"acquired":false,"shares":2891,"price":1.7107,"value":4945.6337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on March 2, 2025. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":70245,"source":{"system":"sec-edgar","filing":"0001650664-25-000025","document":"wk-form4_1741210903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066425000025/wk-form4_1741210903.xml","form_type":"4"}},{"id":1447893,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-07-26T21:02:15.000Z","date":"2024-07-25","kind":"sale","planned":true,"acquired":false,"shares":11886,"price":5.4156,"value":64369.8216,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on July 3, 2023, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on July 24, 2024. The sale does not represent a discretionary trade by the Reporting Person."}],"balance_after":73136,"source":{"system":"sec-edgar","filing":"0001650664-24-000090","document":"wk-form4_1722027729.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000090/wk-form4_1722027729.xml","form_type":"4"}},{"id":1593957,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":74400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on March 2, 2024 and is scheduled to vest over four years in equal monthly installments beginning on  April 2, 2024 through March 2, 2028."}],"balance_after":74400,"derivative":{"exercise_price":10.53,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":74400},"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1593956,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":15055,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Reflects the acquisition, upon the achievement of a specified business development milestone, of a portion of a performance-based restricted stock unit award originally granted on July 24, 2023. The shares subject to the restricted stock unit award remain subject to time-based vesting conditions and will vest on July 24, 2024, subject to continued service."}],"balance_after":85022,"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1593955,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2024-03-06T01:03:36.000Z","date":"2024-03-02","kind":"grant","planned":false,"acquired":true,"shares":24800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years with 25% of the units vesting on March 2, 2025 and the remaining 75% of the units scheduled to vest in equal quarterly installments thereafter through March 2, 2028."}],"balance_after":69967,"source":{"system":"sec-edgar","filing":"0001650664-24-000017","document":"wk-form4_1709686999.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000165066424000017/wk-form4_1709686999.xml","form_type":"4"}},{"id":1823384,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Stock Option (right to  buy)","published_at":"2023-07-25T20:45:05.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":135500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option was granted on July 24, 2023 and is scheduled to vest over four years, with 25% of the shares to vest on July 24, 2024 and the remaining 75% of the shares scheduled to vest in equal monthly installments thereafter through July 24, 2027."}],"balance_after":135500,"derivative":{"exercise_price":8.66,"expiration_date":"2033-07-23","underlying":"Common Stock","underlying_shares":135500},"source":{"system":"sec-edgar","filing":"0001415889-23-011455","document":"form4-07252023_040701.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011455/form4-07252023_040701.xml","form_type":"4"}},{"id":1823383,"issuer":{"id":5502,"kind":"organization","name":"Editas Medicine, Inc.","symbol":"EDIT"},"owners":[{"id":10100,"kind":"person","name":"Burkly Linda","position":1,"cik":"0001985604","reported_name":"Burkly Linda","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, CHIEF SCIENTIFIC OFFICER"}}],"security":"Common Stock","published_at":"2023-07-25T20:45:05.000Z","date":"2023-07-24","kind":"grant","planned":false,"acquired":true,"shares":45167,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The common stock received by the Reporting Person was in connection with the grant of a restricted stock unit award to the Reporting Person, for no consideration, and which is scheduled to vest over four years in equal yearly installments of one-fourth of the shares, with the first such installment to vest on July 24, 2024 continuing through July 24, 2027."}],"balance_after":45167,"source":{"system":"sec-edgar","filing":"0001415889-23-011455","document":"form4-07252023_040701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1650664/000141588923011455/form4-07252023_040701.xml","form_type":"4"}}]}